We are excited to announce this new webcast focusing on the experience of patients undergoing treatment for hematologic malignancies during the COVID-19 era.
This on-demand activity, the fifth in a seven-part series, features a discussion on approaches to limit patient and provider exposure to SARS-CoV-2 while effectively managing hematologic malignancies during the COVID-19 pandemic.
Learning Objectives:
Upon successful completion of this educational activity, participants should be better able to:
- Describe the epidemiology, pathology and current treatment strategies of COVID-19
- Develop approaches to limit patient and provider exposure to SARS-CoV-2 while effectively managing hematologic malignancies
- Evaluate current COVID-19 treatment strategies for potential interactions with anticancer agents
- Identify, mitigate, and manage current and prospective diagnostic, therapeutic, and monitoring challenges in oncology care due to the reallocation of health resources as a result of the COVID-19 pandemic